Physician profile
George M Jabbour
NPI 1912420373
$1,290.81
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.96 · 2020: $150 · 2021: $164 · 2023: $43.07 · 2024: $729 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Honoraria: $42.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.35 |
| Honoraria | $42.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $710.54 | 2024-2025 | |
| Dentsply Sirona INC | $207.55 | 2019-2025 | Cerec, Endo Activator |
| Biolase, INC. | $101.38 | 2020 | |
| Envista Holdings Corporation | $89.54 | 2024-2025 | Harmonize, Optibond Xtr |
| Align Technology, INC. | $74.95 | 2021-2025 | Invisalign |
| Benco Dental Supply Co. | $42.04 | 2024 | |
| Nobel Biocare USA | $14.68 | 2023 | Nobelactive |
| Kerr Corporation | $14.68 | 2023 | Harmonize |
| Philips North America LLC | $13.15 | 2020 | |
| 3m Company | $11.47 | 2019 | |
| Voco America INC. | $10.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Jabbour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.